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THE ROLE OF SEX STEROIDS AND PUBERTY ON RESPIRATORY 
FUNCTION 
CHRISTA MARIE FRODELLA 
ABSTRACT 
Exercise-induced anaphylaxis (EIA) is a rare severe disease in which patients express 
asthmatic and allergic symptoms. Little is known about EIA and its pathology. This 
manuscript presents an hypothesis that combined hormonal (estrogen and progesterone) 
contraceptive use and stress during puberty alter the immune system and predispose the 
adult female to EIA. Presented here is what is known about asthma, a much more 
common disease, and a pilot, experimental paradigm in which EIA is induced in Syrian 
hamsters.  
 
Asthmatic and allergic cases are much more prevalent in pubescent and adult females 
than in adult males. Women express higher levels of lung inflammation at stages of their 
lives when estrogen and progesterone levels are at their lowest (i.e., the follicular phase 
of the menstrual cycle and menopause).  
 
Combined birth control pills have been utilized by doctors to treat asthmatic women. 
Contraceptive treatments maintain steady levels of estrogen and progesterone throughout 
the menstrual cycle.  
 
  vii 
It is hypothesized that if female hamsters are given constant levels of hormones as well as 
ovalbumin and exercise challenges during puberty and then have the hormones taken 
away during adulthood, they will produce abnormal lung sounds and corresponding 
pathological histology. To test this hypothesis, female Syrian hamsters were treated with 
ovalbumin, exercise challenge, both and none (the control). They were also treated to 
maintain constant levels of estrogen and progesterone during puberty. Although the 
results were inconclusive, the model may demonstrate that constant ovarian hormones, 
ovalbumin sensitization, and exercise challenges permanently strain the immune system 
of females in adulthood.  
 
  
  viii 
TABLE OF CONTENTS 
 
TITLE……………………………………………………………………………………...i 
COPYRIGHT PAGE……………………………………………………………………...ii 
READER APPROVAL PAGE…………………………………………………………..iii 
DEDICATION ................................................................................................................... iv 
ACKNOWLEDGMENTS .................................................................................................. v 
ABSTRACT ....................................................................................................................... vi 
TABLE OF CONTENTS ................................................................................................. viii 
LIST OF TABLES ............................................................................................................. xi 
LIST OF FIGURES ......................................................................................................... xiii 
LIST OF ABBREVIATIONS .......................................................................................... xiv 
INTRODUCTION .............................................................................................................. 1 
SPECIFIC AIMS ................................................................................................................ 1 
BACKGROUND AND SIGNIFICANCE .......................................................................... 3 
I. Defining Exercise-Induced Anaphylaxis ............................................................. 3 
II. Gender and the Incidence of Asthma and Allergies ......................................... 4 
III. Sex Steroid Levels and Incidence of Asthma in Females ................................ 6 
a. Prepuberty ............................................................................................................. 7 
b. Puberty................................................................................................................... 8 
  ix 
c. Menstruation ....................................................................................................... 11 
d. Steroid Contraceptive Use ................................................................................. 13 
e. Pregnancy............................................................................................................. 14 
f. Menopause ............................................................................................................ 15 
IV. Sex Steroid Levels in Males ............................................................................. 17 
V. Animal Models: Roles of Sex Steroids in Lung Inflammation....................... 18 
VI. The Role of Sex Steroids on Immune Cells .................................................... 21 
VII. Stress Response, Cortisol, and Asthma during Puberty and Adulthood ... 24 
VIII. Sex Differences in Asthma and Exercise ..................................................... 27 
IX. Hypothesis and Goals of the Present Study ................................................... 29 
METHODS ....................................................................................................................... 31 
I. Animals ................................................................................................................. 31 
II. Contraceptive Patch .......................................................................................... 32 
III. Special Considerations for Surgical Procedures ........................................... 33 
IV. Ovalbumin Sensitization .................................................................................. 34 
V. Acute Ovalbumin Challenge ............................................................................. 34 
VI. Exercise Challenge............................................................................................ 35 
VII. Sacrifice ............................................................................................................ 35 
VIII. Auscultation Protocol .................................................................................... 39 
IX. Histology Protocol ............................................................................................ 40 
RESULTS ......................................................................................................................... 43 
I. Survival................................................................................................................. 43 
  x 
II. Changes in Mass................................................................................................. 46 
III. Contraceptive Efficacy of the Patch ............................................................... 47 
IV. Lung Auscultation ............................................................................................ 48 
V. Histology ............................................................................................................. 48 
DISCUSSION ................................................................................................................... 49 
I. Overview............................................................................................................... 49 
II. Technical Concerns............................................................................................ 49 
III. Conclusions and Future Experiments ............................................................ 52 
REFERENCES ................................................................................................................. 56 
CURRICULUM VITAE ................................................................................................... 63 
 
  
  xi 
LIST OF TABLES 
 
 
Table Title Page 
1 Clinical Presentations of Exercise-Induced Anaphylaxis 3 
2 Common EIA Food Allergens  4 
3 Hormonal Levels for Prepubertal, Pubertal, and Overt 
Pubertal Children 
7 
4 Sex Steroid Concentrations at Various Times Before and 
After Menarche  
9 
5 Characterizing Clinical Stages of Female Puberty 10 
6 Reference Pubescent Testosterone Levels in Boys 11 
7 Hormone Levels in Men, Naturally Cycling Women, and 
Triphasic Oral Contraceptive Users 
12 
8 Sex Steroid Levels in the First and Third Trimesters of 
Normal Human Pregnancy  
14 
9 Sex Steroid Concentrations of Pre-, Peri- and 
Postmenopausal Women  
15 
10 Sex Steroid Concentrations of Pre-, Peri-, and 
Postmenopausal Women 
16 
11 Reference Hormone Levels in Young, Middle-aged, and 
Elderly Men 
18 
  xii 
12 Role of Steroids on Thymus Weight 23 
13 Classification of Auscultations  29 
14 Experimental Treatment Groups 31 
15 Antiovulatory Activity of Progestins 33 
16 Experimental Group I – Control 36 
17 Experimental Group II – Sham Surgery 37 
18 Experimental Group III – Contraceptive Patch Implant 38 
19 Paraffin Embedding Protocol 40 
20 Deparaffinization Protocol 41 
21 Hematoxylin and Eosin Stain Protocol 42 
22 Congo Red (0.5%) Stain Protocol 42 
23 Experimental Female Survival Percentages 44 
24 Average Female Mass Gains 47 
 
 
  
  xiii 
LIST OF FIGURES 
 
 
 
Figure Title Page 
1 Child and Adult Current Asthma Prevalence by Age and 
Sex: United States, 2006-2010 
5 
2 Female vs. Male OVA-Challenged Mice Histology 19 
3 Lung Histology of Control, OVA-challenged, and 
Ovariectomized (before sensitization) OVA-challenged 
Female Mice 
20 
4 Lung Inflammation is Attenuated by Estradiol in a Dose-
Dependent Manner 
21 
5 Ortho EvraTM Estrogen and Progesterone Compounds 32 
6 Timeline of Patch Implantations, OVA treatments, and 
Exercise Challenges 
35 
7 Asthmatic Wheeze 39 
8 Percentage of Females that Survived Treatment 45 
 
 
  
  xiv 
LIST OF ABBREVIATIONS 
A  ................................................................................................................ Androstenedione 
ACTH  ................................................................................... Adrenocorticotropin Hormone 
BALF  ................................................................................... Bronchoalveolar Lavage Fluid 
Bio  .................................................................................................................... Bioavailable 
C ................................................................................................................................ Cortisol 
CBG .................................................................................. Corticosteroid-Binding Globulin 
CDC ................................................................. Centers for Disease Control and Prevention 
CD15 ........................................................................................ Cluster of Differentiation 15 
CMA ............................................................................................... Chiormadinone Acetate 
CO ............................................................................................................................. Control 
CPA ...................................................................................................... Cyproterone Acetate 
CRH…………………………………………………….Corticotropin-Releasing Hormone 
D ...................................................................................................................................... Day 
DG ....................................................................................................................... Desogestrel 
DHEA ............................................................................................ Dehydroepiandrosterone 
DHEAS .............................................................................. Dehydroepiandrosterone Sulfate 
EE ............................................................................................................... Ethinyl Estradiol 
EIA  ...................................................................................... Exercise-Induced Anaphylaxis 
EP  ............................................................................................... Estrogen and Progesterone 
EX ............................................................................................................................ Exercise 
EXS ..................................................................................................Exercise and Sensitized 
  xv 
E1 ............................................................................................................................... Estrone 
E2 ............................................................................................................................. Estradiol 
FDEIA  ..................................................... Food-Dependent Exercise-Induced Anaphylaxis 
FMLP  ............................................. N-formylmethionyl-leucyl-phenylalanine-methylester 
Fol ................................................................................................................ Follicular Phase 
FSH ....................................................................................... Follicle-Stimulating Hormone 
GnRH ............................................................................. Gonadotropin-Releasing Hormone 
HPA.................................................................................... Hypothalamic Pituitary Adrenal 
IgE ........................................................................................................... Immunoglobulin E 
IL .......................................................................................................................... Interleukin 
LH ....................................................................................................... Luteinizing Hormone  
i.p.  ................................................................................................................. Intraperitoneal 
LPS  ........................................................................................................ Lipopolysaccharide 
LTB4  ............................................................................................................. Leukotriene B4 
Lut  .................................................................................................................... Luteal Phase 
NET ................................................................................................................ Norethisterone 
NG ................................................................................................................. Levonorgestrel 
NGM ................................................................................................................ Norgestimate 
NOC ........................................................................................ Non-Oral Contraceptive user 
OC ................................................................................................... Oral Contraceptive user 
OVA .....................................................................................................................Ovalbumin 
Ovx ............................................................................................................... Ovariectomized 
  xvi 
P ........................................................................................................................ Progesterone 
PBS ............................................................................................. Phosphate Buffered Saline 
PMN .................................................................................... Polymorphonuclear Leukocytes 
RIA ......................................................................................................... Radioimmunoassay 
s.c. ................................................................................................................... Subcutaneous 
SHBG ................................................................................. Sex Hormone-Binding Globulin 
SS .......................................................................................................................... Sensitized 
T ........................................................................................................................ Testosterone 
Th ..................................................................................................................... T cell Helper 
TNFα ...................................................................................... Tumor Necrosis Factor Alpha 
17-d-NGM...................................................................................... 17-deacetylnorgestimate 
 
 
 1 
INTRODUCTION 
SPECIFIC AIMS 
Asthma is a complex, respiratory disease that is elicited by a variety of triggers including 
exercise (Akar et al., 2015), cold weather (Strauss et al., 1977), and aspirin (Dekker et al., 
1997). In a specific subset of asthma, exercise-induced anaphylaxis (EIA), exercise 
synergizes with another allergen to produce symptoms (Wong and Mace, 2007).  
Prepubescent boys are more likely than their female peers to develop asthma, but this 
pattern is reversed for adult men and women (Asthma Surveillance Data, 2015). Why the 
switch occurs during puberty is unclear. What is known about puberty is that it is a 
crucial developmental period that is necessary for sexual maturation. Reproductive 
behaviors and physical features are “turned on” and developed, respectively, by 
increasing sex steroid levels.  
 
The pubescent brain’s delicate nature is reflected in animal studies. The stress response, 
mediated by the hypothalamic pituitary adrenal axis (HPA), produces a sex-specific 
response prepubescent female (Romeo et al., 2004) and male (Romeo et al., 2006) rats 
compared to adult conspecifics.  
 
Asthmatic human females have reported attenuation and increased pulmonary symptoms 
at numerous endocrine statuses that reflect high and low levels of estrogen and 
progesterone [i.e., various points of the menstrual cycle (Brenner et al., 2005), pregnancy 
(Schatz et al., 1988), and menopause (Troisi et al., 1995)].  
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To date, there has been limited research on the impact of female combined (estrogen and 
progesterone) contraceptives on asthma and no research on the effect of long term 
hormonal contraceptive use during puberty on asthma in adolescence and adulthood.  
Therefore, this thesis seeks to investigate whether alteration of the natural cycle of sex 
hormones in females during puberty increases the predisposition to, and severity of, 
existing asthma. A Syrian hamster model was utilized to address the following specific 
objectives: 
Objective #1: To determine if exposure to combined contraceptives (estrogen and 
progesterone) during puberty and return to estrus in adulthood increases abnormal lung 
sounds (i.e., wheezing) and eosinophil and neutrophil migration into the lungs. 
Objective #2: To determine if exposure to combined contraceptives and sensitization to 
an allergen (i.e., ovalbumin) during puberty increases abnormal lung sounds and 
eosinophil and neutrophil migration into the lungs significantly more than females 
exposed to contraceptives alone.  
Objective #3: To determine if exposure to combined contraceptives during puberty, 
sensitization to ovalbumin, and exercise produces increased abnormal lung sounds and 
histologically-identifiable alterations in comparison to non-exercised females and non-
exercised females exposed to contraceptives and sensitized to ovalbumin.  
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BACKGROUND AND SIGNIFICANCE 
I. Defining Exercise-Induced Anaphylaxis 
Patients with EIA react to an exercise challenge and a particular allergen (Wong and 
Mace, 2007) with a wide range of clinical manifestations (Table 1; Castells et al., 2003).  
Table 1. Clinical Presentations of Exercise-Induced Anaphylaxis. Table was copied from 
Castells et al., 2003. 
Symptom Percentage (%) 
Pruritus 92 
Urticaria 86 
Angioedema 72 
Flushing 70 
Shortness of breath 51 
Dysphagia 34 
Chest tightness 33 
Syncope 32 
Profuse sweating 32 
Headache 28 
G.I. symptoms (nausea, diarrhea, colicky pain) 28 
Choking, throat constriction, hoarseness 25 
 
There are multiple types of EIA. Food-dependent EIA (FDEIA) is a specific subset of 
this disease that requires the ingestion of a food allergen around the time of exercise 
(Bonini and Palange, 2014). Common food triggers include wheat, shellfish, and peanuts 
(Table 2; Bonini and Palange, 2014).  
 
 
 4 
 
Table 2. Common EIA Food Allergens. Table was copied and amended from Bonini and 
Palange 2014. 
Common EIA Food Allergens  
(1) Grains/Cereals: wheat (specifically w-5-gliadin allergen), buckwheat, barley, 
and oats 
(2) Foods contaminated with aero-allergens: house dust mite, penicillium mold 
(3) Seafood: fish and shellfish 
(4) Seeds: mustard and sesame 
(5) Nuts: peanuts and tree nuts 
(6) Vegetables and fruits: onion, tomato, celery, soy, red bean, orange, and grape 
(7) Meat: pork and beef 
(8) Miscellaneous: cow’s milk, wine, and mushrooms 
 
Case reports also present non-food triggers: swimming in cold but not warm water 
(Benhamou et al., 2007), aspirin (Micucci et al., 2014), and menstruation (Fischer et al., 
2010). Treatments for EIA are not well developed.  As with allergies and asthma, there is 
no cure (Barg et al., 2011). 
 
To date, there are no experimental paradigms that aim to understand the pathophysiology 
of EIA. As EIA is a combination of allergic and asthmatic symptoms, it is appropriate to 
explore what is known about these relevant diseases and the models used to study them. 
II. Gender and the Incidence of Asthma and Allergies 
According to the Asthma Surveillance Data from the CDC, there is a clear gender 
difference in asthma pathology that is evident at two distinct time frames:  (1) before the 
age of 14, boys are more likely than girls to have asthma and (2) in adulthood, women are 
more likely than men to have asthma. The asthma gender disparity equals out between 
ages 15-17 (Figure 1; Asthma Surveillance Data, 2015). 
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Figure 1. Child and Adult Current Asthma Prevalence by Age and Sex: United States, 
2006-2010. Boys were more likely than girls to have asthma during ages 0-14. Both 
sexes, 15-17 years old, had equal prevalence of asthma. In adulthood (ages 18 and above) 
women were more likely than men to have asthma. Figure taken from Centers for Disease 
Control and Prevention website http://www.cdc.gov/asthma/asthmadata.htm. 
Gender and age disproportions are also evident in the incidence of allergies. Before the 
age of ten, boys are three times more likely to test positive for a skin prick test for house 
dust mite allergens than girls (Wormald, 1977). Women in their 20’s and 30’s were 1.5 to 
1.6 times more likely than men to show a positive skin prick test (Wormald, 1977).  
As puberty is the transitional period when females become more likely than males to 
develop asthma and allergies, it is plausible that sex steroids may play a role in the 
pathological mechanism. 
 
White blood cell counts have also been shown to differ by gender. Total leukocyte counts 
are significantly greater in women, likely due to a greater neutrophil population. There 
were no significant differences in lymphocyte, monocyte, and eosinophil counts between 
men and women (Bain and England, 1975a). Since neutrophilia is characteristic of lung 
0
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inflammation (Moore et al., 2014), gender differences in white blood cell counts may 
contribute to the greater propensity for women to develop asthma compared to men.  
III. Sex Steroid Levels and Incidence of Asthma in Females 
In sexually mature males and females, follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH) are key regulatory hormones that are secreted by the pituitary. 
FSH is responsible for stimulating the growth and maturation of ovarian follicles and 
spermatogenesis in females and males, respectively. LH stimulates the secretion of sex 
steroids. LH and FSH are regulated by gonadotropin-releasing hormone (GnRH), which 
is secreted by the hypothalamus (Marshall and Kelch, 1986). As these hormones are of 
interest to this study, they will be further explored to understand the critical changes that 
occur in their levels throughout life. Table 3 summarizes the transitional hormonal values 
(Garcia-Mayor et al., 1997). 
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Table 3. Hormonal Levels for Prepubertal, Pubertal, and Overt Pubertal Children. 
Menstruating girls were not matched for corresponding days in their cycle. Testosterone 
and estrogen levels were not measured in girls and boys, respectively. Values represents 
mean ± standard deviation. Table was modified and copied from Garcia-Mayor et al., 
1997. 
Characteristic 
Prepubertal Pubertal Overt Pubertal 
Girls Boys Girls Boys Girls Boys 
Age (year) 
8.37± 
0.14 
8.85 ± 
0.12 
11.22 ± 
0.22 
12.65 ± 
0.19 
12.69 ± 
0.13 
13.38 ± 
0.12 
T (µmol/L) ----------- 
0.003 ± 
0.00001 
----------- 
0.00316 
± 0.0002 
----------- 
0.0119 ± 
0.005 
E2 (pmol/L) 
19.8 ± 
0.2 
----------- 
64.5 ± 
2.5 
----------- 
274.7 ± 
25.1 
----------- 
FSH (IU/L) 
1.6 ± 
0.09 
1.06 ± 
0.04 
4.4 ± 0.4 
2.13 ± 
0.1 
4.7 ± 0.2 3.3 ± 0.1 
LH (IU/L) 
0.1 ± 
0.03 
0.1 ± 
0.00 
1.1 ± 0.2 
0.3 ± 
0.06 
2.9 ± 0.4 
0.8 ± 
0.07 
 
Females experience at least six distinct sex steroid level statuses in their lifetime: (i) 
prepubescent (Garcia-Mayor et al., 1997), (ii) pubescent (Sizonenko et al., 1970), (iii) 
adulthood (Timmons et al., 2005), (iv) hormonal contraceptive use (Dericks-Tan et al., 
1992), (v) pregnancy (O’Leary et al., 1991), and (vi) menopause (Slemenda et al., 1996 
and Pasquali et al., 1997). For each hormonal status, female asthmatics have reported 
worsening and/or improvement of asthma symptoms (Brenner et al., 2005; Hong et al., 
2014; Macsali et al., 2009; Mandhane et al., 2009; Romieu et al., 2010; Schatz et al., 
1988; Skobeloff et al., 1992; and Troisi et al., 1995).  
a. Prepuberty 
The prepubescent years are marked by low sex steroid (estradiol, LH, FSH) levels. Girls 
are categorized as prepubertal if their estradiol levels are less than 36.57 pmol/L (Table 3; 
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Garcia-Mayor et al., 1997). Boys are categorized as prepubertal if their testosterone 
levels are less than 1.74 nmol/L (Garcia-Mayor et al., 1997). 
 
A retrospective study on hospital admissions showed that boys between the ages of 0-10 
were twice as likely to be admitted for asthma in comparison to age identical girls 
(Skobeloff et al., 1992). Another study that focused on the prevalence of asthma in 11-
year old girls and boys, 54% of boys and 24% of girls had physician-diagnosed asthma. 
This difference was found to be statistically significant. There was also a significant and 
positive correlation in serum IgE levels and prevalence of asthma. Although average 
serum IgE levels were increased in boys (120.8 IU/mL) compared to girls (98.1 IU/mL), 
this was not found to be statistically different (Sears et al., 1991).  
b. Puberty 
In females, puberty has been defined as the period of time from the onset of secondary 
sexual characteristics that include breast development and pubic hair growth (Marshall 
and Tanner, 1969) to menses and ovulation (Martí-Henneberg and Vizmanos, 1997). The 
progression and development of secondary sexual characteristics reflect increasing 
reproductive hormone levels (Sizonenko et al., 1970). Reproductive hormones increase as 
the body approaches menarche and after the onset of menses (Table 4; Lucky et al., 
1997).  
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Table 4. Sex Steroid Concentrations at Various Times Before and After Menarche. 
Values indicate the median (range). Table copied and amended from Lucky et al., 1997.  
 Sex Steroid Concentrations 
Months from 
Menarche 
T (µmol/L) Free T (µmol/L) E2 (pmol/L) P (nmol/L) 
-48  
(n=28) 
0.31  
(0.03-1.70) 
0.005  
(0.0007-0.05) 
22 
 (7-59) 
0.60 
 (0.19-2.16) 
-36  
(n=70) 
0.31  
(0.01-2.67) 
0.006  
(0.001-0.08) 
28  
(7-209) 
0.67  
(0.19-4.74) 
-24  
(n=87) 
0.42  
(0.01-2.95) 
0.009  
(0.0007-0.06) 
53  
(7-1057) 
0.87  
(0.06-8.30) 
-12  
(n=130) 
0.80  
(0.10-3.85) 
0.017 
 (0.001-0.12) 
184  
(11-1421) 
2.32 
 (0.25-12.34) 
Menarche  
(n=149) 
1.21  
(0.03-5.66) 
0.28  
(0.001-0.15) 
341  
(22-3018) 
3.66  
(0.22-58.77) 
12  
(n=183) 
1.35  
(0.24-6.00) 
0.035  
(0.004-0.17) 
410  
(18-2507) 
5.60  
(0.03-77.46) 
24  
(n=127) 
1.46  
(0.21-3.64) 
0.038  
(0.003-0.11) 
423  
(18-3574) 
6.68  
(0.51-81.43) 
36+  
(n=94) 
1.56  
(0.45-4.30) 
0.039  
(0.009-0.16) 
377  
(18-3021) 
5.31  
(0.92-59.43) 
 
Clinicians assess pubertal progression through the five stages of pubertal development 
(Table 5; Tanner, 1962) by physical examination.  
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Table 5. Characterizing Clinical Stages of Female Puberty. Table adapted from Tanner, 
1962. 
Pubertal Stage (P) Clinical Characteristics 
P1 (Prepuberty)  No clinical signs of puberty 
P2 
 Breast buds 
 Few pubic and/or axillary hairs 
 Minimal change in vaginal mucosa 
 Early development of the labia 
majora and minora 
P3 
 Increased fullness of breasts 
 Projection of areola and nipples 
 Presence of Montgomery follicles 
 Moderate enlargement of labia 
majora and minora 
 Dullness of vaginal mucosa 
P4 
 Well-developed breasts and external 
genitals 
 Moderate to abundant pubic and 
axillary hair 
 No menarche 
P5  Post-menarche 
 
The onset and duration of puberty vary in females. The duration of puberty is dependent 
upon age of onset. Martí-Henneberg and Vizmanos (1997) reported that girls who started 
puberty earlier were likely to have a greater duration of puberty. This suggests that the 
pubertal window varies for each girl.  
 
One study suggests that early onset of puberty in females may be linked to a greater risk 
for asthma (Hong et al., 2014). In this study, early pubarche was defined as reaching 
pubertal stage 2 before 10 years of age (Hong et al., 2014). Menarche before age 11 
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(Macsali et al., 2011) and 12 (Lieberoth et al., 2015) years old was also associated with 
increased risk of developing asthma. Future studies are needed to explore the connection 
between early onset of puberty and menses and greater incidence of asthma in females.  
 
In males, puberty is characterized by the rising levels of testosterone (Table 6; Martha et 
al., 1989).  
Table 6. Reference Pubescent Testosterone Levels in Boys. Early pubescent testosterone 
levels are significantly less than Late and Post Pubescent testosterone levels (P<0.05). 
Late and Post testosterone levels are statistically similar (P<0.05) but significantly less 
than Adult testosterone concentrations (P<0.05). Serum samples were taken at 0600. 
Table amended and copied from Martha et al., 1989. 
Testosterone Concentrations 
Mean ± SE (nmol/L) 
Pubescent Time Frames 
Adult 
Pre Early Late Post 
Undetectable 
(<0.87) 
4.78 ± 1.25 14.73 ± 1.14 17.11 ± 1.11 21.29  1.56 
c. Menstruation 
Menstruation is characterized by the cyclical rise and fall of estrogen and progesterone in 
the follicular and luteal phases (Table 7; Timmons et al., 2005).  
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Table 7. Hormone Levels in Men, Naturally Cycling Women, and Triphasic Oral 
Contraceptive Users. aSignificantly different from men, P ≤ 0.05. bSignificantly different 
from men, P ≤ 0.0125. cMain effect for group (OC < NOC), P ≤ 0.05. dMain effect for 
group (OC > NOC), P=0.058. eMain effect for phase (Lut > Fol), P ≤ 0.05. fInteraction 
effect, significantly different from LUT in NOC, P = 0.02. gInteraction effect, 
significantly different from Fol within NOC, P = 0.02. Table copied from Timmons et al., 
2005. 
 NOC OC 
Hormone Men Fol Lut Fol Lut 
E2 pmol/L 134 ± 70 195 ± 188 361 ± 263a 42 ± 41ac 14 ± 11bc 
P nmol/L 2.9 ± 1.0 1.8 ± 0.4a 10.3 ± 8.3beg 1.9 ± 0.6ac 1.9 ± 0.6acef 
T nmol/L 19.9 ± 3.7 1.2 ± 0.2b 1.0 ± 0.4b 0.7 ± 0.2bc 0.7 ± 0.1bc 
C nmol/L 570 ± 145 527 ± 433 535 ± 540 1,364 ± 772bd 1,355±818bd 
 
The menstrual cycle can further be separated into 4 time frames: preovulatory (days 5-
11), periovulatory (days 12-18), postovulatory (days 19-25), and perimenstrual (days 26-
4). An exacerbation of asthma symptoms may occur at various times of the menstrual 
cycle. Asthmatic women had the following menstrual cycle phase triggers: (1) 28% 
preovulatory, (2) 22% periovulatory, (3) 22% postovulatory, and (4) 27% perimenstrual 
(Brenner et al., 2005). Another study found similar results: 33% of asthmatic episodes 
were preovulatory, 26% were periovulatory, 20% were postovulatory, and 21% were 
perimenstrual (Zimmerman et al., 2000). The incidence of asthma episodes at each phase 
of the menstrual cycle did not differ statistically (Brenner et al., 2005; Zimmerman et al., 
2000). 
 
The cyclical nature of menstruation also has had an observable and cyclical effect on 
white blood cell counts. In a small study, 4 cycling women had increased and decreased 
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neutrophil counts that corresponded to high and low ovarian hormone concentrations, 
respectively, throughout the menstrual cycle (Bain and England, 1975b).  Neutrophilia is 
characteristic of lung inflammation in asthmatics (Moore et al., 2014). As such, if 
neutrophil counts increase during days of increased estrogen and progesterone, this may 
account for why some women have exacerbated asthma symptoms during the luteal 
phase.  
d. Steroid Contraceptive Use 
Combined hormonal (estrogen and progesterone) contraceptives are one of the most 
widely used anti-fertility drugs. Combined contraceptives prevent pregnancy primarily by 
blocking ovulation (Dericks-Tan et al., 1992). Ovulation is prevented through inhibition 
of mid-cycle peaks of FSH and LH (Dericks-Tan et al., 1992).  
 
Steroid contraceptives, such as ethinyl estradiol and 17-deacetylnorgestimate in Ortho 
EvraTM, reduce endogenous sex steroid levels (Table 7; Timmons et al., 2005). Synthetic 
steroid levels are not included in Table 7. A separate assay is needed to assess synthetic 
steroid serum concentrations (Kharma et al., 1972). A single study that measures both 
endogenous and synthetic steroid levels is not found in the literature.  
 
One study indicated that oral contraceptives increase symptoms associated with asthma 
and hay fever in comparison to those reported by non-oral contraceptive users (Macsali et 
al., 2009). Another study showed a significant reduction of exhaled nitric oxide, a marker 
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of respiratory inflammation, in OC users compared to NOC users (Mandhane et al., 
2009).  
e. Pregnancy 
Pregnancy is characterized by increases in estrogen, progesterone, and testosterone that 
peak in the third trimester (Table 8; O’Leary et al., 1991).  
Table 8. Sex Steroid Levels in the First and Third Trimesters of a Normal Human 
Pregnancy. Values are the mean hormone levels and (range). Table copied from O’Leary 
et al., 1991.  
 Gestation Time 
Hormone  
(nmol/L) 
5 Weeks 40 Weeks 
Estradiol 1.64 (0.69-3.88) 53.44 (22.53-127) 
Progesterone 49 (26-91) 584 (314-1087) 
Testosterone 3.3 (0.9-7.4) 5.7 (2.2-10.8) 
 
In a prospective study of 366 pregnancies, 35% of asthmatic women reported worsening 
of their asthma symptoms, 28% felt improvement, and 33% had unchanged symptoms. 
Of the 28% of pregnant women who reported an improvement of asthma symptoms, the 
final four weeks of gestation was reported to be the period with the most significant 
attenuation of symptoms. During the first three months post-partum, 73% of women 
reported returning to pre-conception asthma symptoms (Schatz et al., 1988). Why 
pregnancy attenuates asthma symptoms in some women but exacerbates or causes it in 
others remains to be elucidated. 
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f. Menopause 
Women who reach peri- and postmenopause undergo a decrease in sex hormones (Table 
9; Slemenda et al., 1996) and an increase in gonadotropins (Table 10; Pasquali et al., 
1997).  
Table 9. Sex Steroid Concentrations of Pre-, Peri-, and Postmenopausal Women. 
Women were considered to be premenopausal if they were between ages 30-48, were 
menstruating regularly, and had FSH levels <15 mIU. Perimenopausal women were 
enrolled in the study if they were between ages 48-59, continued to menstruate, and had 
FSH levels ≥ 15 mIU. Women were considered postmenopausal if their last menses 
occurred at least one year before the study. Values represent mean (± standard deviation). 
Table amended and copied from Slemenda et al., 1996. 
 Menopausal Status 
Sex 
Steroid 
Pre-Menopause 
(n=96) 
Peri-Menopause 
(n=62) 
Post-Menopause 
(n=73) 
E1 
(pg/mL) 
47.0 (14.6) 40.6 (16.2) 31.8 (7.8) 
E2 
(pg/mL) 
47.5 (18.7) 28.8 (17.4) 20.0 (4.8) 
T 
(ng/mL) 
0.23 (0.10) 0.16 (0.09) 0.18 (0.11) 
A 
(ng/mL) 
1.13 (0.34) 0.62 (0.30) 0.66 (0.29) 
P 
(ng/mL) 
0.17 (0.19) 0.19 (0.22) 0.07 (0.05) 
DHEA 
(ng/mL) 
2.20 (0.94) 1.61 (0.81) 1.02 (0.75) 
DHEAS 
(µg/mL) 
1.60 (0.82) 1.25 (0.22) 0.77 (0.61) 
SHBG 
(nm/L) 
63.2 (26.9) 60.4 (27.1) 54.4 (22.3) 
 
 
 
 
 
 16 
Table 10. Sex Steroid Concentrations of Pre-, Peri-, and Postmenopausal Women. Data 
values are mean ± standard deviation. Women were characterized as premenopausal if 
they had at least 10 regular menstrual cycles without menopausal symptoms (i.e. hot 
flashes and mood changes). Perimenopausal women were defined as having at least one 
period in the previous 6 months and/or presenting with typical menopausal symptoms. 
Women were enrolled as postmenopausal if they had estradiol levels lower than 150 
pmol/L, FSH levels greater than 15 IU/L, had bilateral ovariectomy and hysterectomy or 
had no menses. Pasquali et al., (1997) states in the caption for this table “Symbols 
reported in each column refer to the comparison between each group and the others 
(ANCOVA), after adjusting for age: a: P < 0.01 for post- versus premenopause. b: P < 
0.01 for post- versus premenopause. [Asterisk]* refers to progressive effects of the 
menopausal status evaluated by the ANCOVA trend, after adjusting for age values; ± 
indicates significant increasing/decreasing trend, passing from pre-, peri-, to 
postmenopause.” Table was copied and amended from Pasquali et al., 1997. 
 
Menopausal Status 
 
Sex 
Hormone 
Premenopause 
(n=133) 
Perimenopause 
(n=97) 
Postmenopause 
(n=196) 
ANCOVA 
trend* 
(P-value) 
LH 
(IU/L) 
5.5 ± 5.9 16.1 ± 13.9a 26.7 ± 12.0a,b +0.001 
FSH 
(IU/L) 
10.2 ± 7.3 50.1 ± 41.5a 100.3 ± 35.4a,b +0.001 
T 
(nmol/L) 
0.98 ± 0.49 1.00 ± 0.49 0.79 ± 0.40a,b -0.004 
E2 
(pmol/L) 
356.2 ± 264.9 237.4 ± 286.2a 56.4 ± 57.0a,b -0.001 
SHBG 
(nmol/L) 
38.7 ± 17.9 37.3 ± 20.2 36.6 ± 17.5 Non-significant 
 
Postmenopausal women may have asthmatic symptoms due to an array of hormonal 
causes. In a prospective cohort study, it was found that postmenopausal women had a 
lower incidence of asthma compared to premenopausal women (Troisi et al., 1995). The 
risk for asthma was greater in postmenopausal women who had past or current use of 
hormone replacement therapy (Troisi et al., 1995).  Notably, there was a slight but 
significant increased risk for developing asthma for past oral contraceptive users (Troisi 
et al., 1995). In another prospective study, menopausal, non-smoking women with a 
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history of allergies were more likely to be diagnosed with asthma after treatment with 
estrogen-alone menopausal hormone replacement therapy (Romieu et al., 2010).  
IV. Sex Steroid Levels in Males 
In men, an increase in age is characterized by declining bioavailable testosterone and 
estradiol (Table 11; Khosla et al., 2001). In a large study in men, increased testosterone 
and dihydrotestosterone levels were associated with greater lung function (Mohan et al., 
2015). There was no significant correlation between lung function and estradiol level in 
men (Mohan et al., 2015). No correlations were found between sex steroid levels and the 
incidence of asthma (Mohan et al., 2015). However, men who reported recent 
occurrences of wheezing had reduced levels of testosterone and dihydrotestosterone 
(Mohan et al., 2015). 
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Table 11. Reference Hormone Levels in Young, Middle-aged, and Elderly Men. Men 
were divided into 3 age groups: Young (aged 20-39 years), Middle-aged (40-59 years), 
and Elderly (60-90 years). Data represents medians (interquartile ranges). The P-value 
column represents the statistical significance across the groups. The following are 
statistically different across the groups: Age, T, Bio E2, SHBG, and Bio T. Hormones E2 
and E1 are not statistically different across the groups.  a P < 0.05 vs. Young. b P < 0.05 
vs. Middle-aged. Table copied and amended from Khosla et al., 2001. 
 Young Middle-aged Elderly 
P 
value 
n 88 97 130  
Age (year) 
30.5 
(27.5, 35.8) 
49.4 
(45.0, 54.9) 
73.3 
(66.1, 82.1) 
<0.001 
T (nmol/L) 
18.5 
(14.4, 22.5) 
16.3 
(13.9, 21.1) 
16.6 
(12.8, 19.8)a 
0.019 
Bio T(nmol/L) 
5.7 
(4.8, 7.1) 
4.3 
(3.4, 5.7)a 
3.0 
(2.2, 3.8)a,b 
<0.001 
E2 (pmol/L) 
110 
(88, 132) 
103 
(88, 121) 
110 
(84, 140) 
0.446 
Bio E2 (pmol/L) 
59 
(44, 73) 
48 
(40, 66)a 
40 
(26, 55)a,b 
<0.001 
E1 (pmol/L) 
133 
(111, 167) 
133 
(104, 159) 
126 
(96, 155) 
0.163 
SHBG (nmol/L) 
24 
(15, 35) 
25 
(17, 44) 
45 
(34, 58)a,b 
<0.001 
 
V. Animal Models: Roles of Sex Steroids in Lung Inflammation 
There are conflicting reports about the role of estrogen in lung inflammation. Melgert et 
al. (2005) present evidence that there is a sex difference in the pathology of allergic lung 
inflammation in mice. OVA-challenged female mice exhibit more severe airway 
inflammation in comparison to OVA-challenged male mice (Figure 2; Melgert et al., 
2005).  The authors note overall increases in eosinophils, neutrophils, and macrophages. 
They did not count the numbers of these white blood cells nor did they assess the 
statistical significance of this finding.  
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Figure 2.  Female vs. Male OVA-Challenged Mice Histology. Experimental mice lung 
tissue histology were sliced at 3µm and stained with hematoxylin and eosin. Females (a) 
show increased airway inflammation in comparison to male mice (b). Magnification is at 
x25. Image copied from Melgert et al., 2005. 
 
Melgert et al. (2005) present statistically significant evidence that OVA-sensitized 
females had a greater infiltration of eosinophils in BALF compared to OVA-sensitized 
males. 
 
Riffo-Vasquez et al. (2007) show that reducing sex steroid levels via ovariectomy 
attenuates lung inflammation as evidenced by reduced numbers of eosinophils (Figure 3; 
Riffo-Vasquez et al., 2007). Estrogen also blocked in allergic, intact females with 
tamoxifen (7 mg/kg i.p) treatments and lung eosinophil migration that was similar to that 
of mice that were ovariectomized. However, estrogen (10 µg/mouse) replacement in 
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allergic, ovariectomized mice does lead to a statistically significant difference in 
eosinophil recruitment as compared to ovariectomized females (Riffo-Vasquez et al., 
2007).  
 
Figure 3. Lung Histology of Control, OVA-challenged, and Ovariectomized (before 
sensitization) OVA-challenged Female Mice. Lung tissue collected 24 hours after OVA 
challenge in (a) control animals (C/Sham), (b) OVA-sensitized (OVA/Sham), and (c) 
Ovariectomized a week before OVA sensitization (OVA/Ovx). There is an increased 
number of eosinophils surrounding the bronchioles in panels (b) and (c). The bar 
represents 40μm. Figure reproduced from Riffo-Vasquez et al., 2007. 
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Dimitropoulou et al. (2009) showed that high levels of estradiol reduce ovalbumin-
induced pathological findings in allergic, female mice. Females were ovariectomized and 
implanted with slow-release estrogen pellets at varying concentrations (160, 56, 0.56, and 
0 µg/day E2). The maximum dosage of estradiol (160 µg/day) significantly inhibited key 
characteristic signs of lung inflammation including reduced BALF total cell counts, 
decreased serum total IgE levels, and attenuation of mucus-secreting goblet cells as seen 
in Figure 4 (Dimitropoulou et al., 2009). 
 
Figure 4. Lung Inflammation is Attenuated by Estradiol in a Dose-Dependent Manner.  
Tissue stained with periodic acid-Schiff stain to visualize mucus-secreting goblet cells. 
The top photos are zoomed out in comparison to the bottom photos. From left to right, the 
pictures represent the control and increasing doses of estrogen from 0 µg/day to 160 
µg/day. Mucus secretion was significantly reduced in females given the highest dosage of 
estrogen. Figure copied from Dimitropoulou et al., 2009.  
VI. The Role of Sex Steroids on Immune Cells 
Asthma is a complex, immune-mediated disease. Some of the key mediators that are 
quantified in asthma studies are the following: eosinophils (Lemière et al., 2006), 
neutrophils (Moore et al., 2014), T helper type 2 cells (Oeser et al., 2015), inflammatory 
cytokines (i.e., IL-4, IL-5, and IL-13) (Liu et al., 2015), and IgE (Sears et al., 1991).  
Control Estrogen Pellet Concentrations (µg/day) 
PBS 0 0.56 56 160 
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Estrogen also has a direct effect on the immune cell level. El-Desouki et al. (2013) 
showed that the inflammatory marker CD15, an antigen that is present in more than 95% 
of mature eosinophils and 5% of monocytes, neutrophils, and macrophages, was greatly 
reduced in ovalbumin-sensitized male mice injected with estrogen. The study did not 
include female mice and it is not known if estrogen significantly decreases CD15 in 
allergic female mice.  
 
The effect of estrogen on the chemotaxis of polymorphonuclear cells (PMN) was tested 
on isolated human neutrophils. Neutrophil chemotaxis was significantly reduced in the 
presence of estradiol to LTB4 and FMLP, both positive chemoattractants (Ito et al., 1995). 
Chemotaxis was restored in the presence of tamoxifen and clomiphene, both estrogen 
receptor antagonists (Ito et al., 1995).  
 
The thymus is a specialized organ of the adaptive immune system where T-cells undergo 
maturation (Larson et al., 2010). More importantly, T-cells are implicated in numerous 
inflammatory diseases, including asthma (Ghonim et al., 2015). The thymus naturally 
undergoes involution after puberty (Pazirandeh et al., 2004). However, Kuhl et al. (1983) 
demonstrate that various preparations of combined contraceptives speed up the involution 
of the thymus in intact female rats. The rate of thymic involution is calculated by 
measuring the thymic weight at weekly intervals. Ethinyl estrogen alone and combined 
with large doses of progestin significantly decreased the thymus weight that is 
characteristic of thymic involution (Table 12; Kuhl et al., 1983). 
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Table 12. Role of Steroids on Thymus Weight. Effect of daily s.c. injections of various 
contraceptive steroid preparations upon female rat thymus weight (mean ± S.D.) during a 
treatment period of 4 weeks, and for 2 weeks after discontinuation. The estrogen, EE 
(Ethinyl Estradiol) and the following progestins were used: NG (Levonorgestrel), DG 
(Desogestrel), NET (Norethisterone), CMA (Chlormadinone Acetate), and CPA 
(Cyproterone). Asterisks** indicate statistically different from control (P < 0.01). Table 
was copied from Kuhl et al., 1983.  
Preparation 1 week 2 weeks 3 weeks 4 weeks 
2 weeks after 
discontinuation 
Control 335 ± 88 302 ± 38 291 ± 27 273 ± 74 262 ± 60 
50 µg EE 134 ± 26** 71 ± 13** 75 ± 42** 67 ± 20** 158 ± 40** 
125 µg NG 330 ± 58 317 ± 58 270 ± 39 303 ± 66 320 ± 48 
125 µg DG 368 ± 90 357 ± 59 315 ± 46 285 ± 52 272 ± 27 
30 µg EE + 125 µg NG 122 ± 32** 83 ± 22** 60 ± 6** 85 ± 12** 95 ± 15** 
30 µg EE + 250 µg NG 129 ± 16** 88 ± 11** 36 ± 8** 87 ± 9** 102 ± 15** 
50 µg EE + 125 µg NG 108 ± 46** 106 ± 23** 64 ± 29** 64 ± 28** 117 ± 18** 
50 µg EE + 500 µg NG 90 ± 12** 35 ± 10** 17 ± 8** 39 ± 18** 41 ± 20** 
30 µg EE + 125 µg DG 156 ± 32** 55 ± 13** 52 ± 7** 70 ± 13** 111 ± 21** 
50 µg EE + 125 µg DG 97 ± 19** 78 ± 14** 53 ± 8** 128 ± 38** 118 ± 34** 
50 µg EE + 2 mg CMA 90 ± 29** 33 ± 7** 22 ± 9** 17 ± 3** 95 ± 35** 
50 µg EE + 2 mg CPA 81 ± 18** 47 ± 17** 29 ± 8** 31 ± 14** 90 ± 40** 
50 µg EE + 2 mg NET 78 ± 21** 23 ± 14** 41 ± 18** 22 ± 6** 42 ± 39** 
** =  P<0.01 
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VII. Stress Response, Cortisol, and Asthma during Puberty and Adulthood 
The immune system is linked to the brain by control of the hypothalamic-pituitary 
adrenal axis (HPA). The hypothalamus releases corticotropin-releasing hormone (CRH) 
that acts on the anterior pituitary. The anterior pituitary then releases adrenocorticotropin 
hormone (ACTH) that signals the adrenals to release cortisol. This process is under 
control through negative feedback.  
 
Asthmatics tend to have lower endogenous cortisol levels then non-asthmatics (Ritz et al., 
2011). Glucocorticoids are often the first line of treatment for severe asthma symptoms 
(Fanta et al., 1982). Glucocorticoid treatment reduces profibrotic inflammatory cytokines, 
IL-11 and IL-17 (Chakir et al., 2003), and airway hyperresponsiveness (Lim et al., 1999). 
Some asthmatic patients have a reduced sensitivity to glucocorticoid treatment that may 
be attributed to a defect in expression of glucocorticoid receptor in airway smooth muscle 
cells (Chang et al., 2015).  
 
There are also sex differences in the release of cortisol through the hypothalamic-
pituitary adrenal axis. In a study on pubescent children, girls had a greater baseline and 
output of cortisol in response to a corticotropin-releasing hormone challenge compared to 
their male peers (Stroud et al., 2011).  
 
When female and male Winstar rats were stressed in adolescence (37-48 days old) and 
challenged with LPS in adulthood, females had significantly elevated levels of 17β-
 25 
estradiol (Pyter et al., 2013). Male rats that underwent the same protocol showed 
significantly increased gene expression of neuroinflammatory markers [IL-1β, TNFα, and 
IκBα (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, 
alpha)] in the hippocampus (Pyter et al., 2013). This evidence suggests that increased 
levels of estradiol may protect against neuroinflammation (Pyter et al., 2013). If LPS can 
induce an inflammatory response in the brain and increase estradiol levels, then it is 
plausible that increased estradiol could have a protective effect in the lungs.  
 
Another experiment by Girard-Joyal et al. (2015) analyzed the stress response to LPS in 
peripubertal/adolescent and adult male and female mice. Adult females had significantly 
greater corticosterone (analogous to human cortisol) levels compared to 
peripubertal/adolescent females and both adult and peripubertal/adolescent males 
(Girard-Joyal et al., 2015). Increased corticosterone levels in only adult, female mice 
suggest that their stress response is different than those of peripubertal females and 
peripubertal and adult males. Since peripubertal/adolescent females did not release as 
much corticosterone as the adult females, it is plausible to hypothesize the HPA axis 
undergoes transformation during puberty so that it can release greater corticosterone 
levels in adulthood.   
 
In female rats, stress during the prepubescent period causes significantly different 
responses in female adult rats (Romeo et al., 2004). In response to restraint, intact pre-
pubertal females display an elevated and sustained level of corticosterone compared 
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to intact adult females.  At baseline, intact adult females had greater estradiol levels. 
Although estrogen increased in response to stress in both prepubertal and adult females, 
there was no significant change 60 minutes after the release from the restraint. 
Progesterone concentrations similarly increased immediately in response to stress in both 
prepubertal and adult females and the levels were statistically different from baseline and 
30 minutes after the stressor. In a second experiment, ovariectomized pre-
pubertal females had significantly greater and sustained levels of corticosterone and 
progesterone compared to ovariectomized adults (Romeo et al., 2004). 
 
A similar study by Romeo et al. (2006) was conducted on pre-pubescent and adult male 
rats with chronic and acute stress models of restraint. All pre-pubertal males had 
significantly lower testosterone levels than the adults, regardless of the stressor type. 
Chronically stressed pre-pubescent male rats had higher ACTH and corticosterone levels 
than adult males but returned to baseline levels much quicker. Acutely stressed pre-
pubertal males had significantly elevated and sustained levels of ACTH and 
corticosterone than the acutely stressed adults (Romeo et al., 2006).  
 
Both reports by Romeo et al. (2004 and 2006) present evidence that the developmental 
period in both males and females has different stress responses compared to the stress 
response of adults and this may be mediated by gonadal hormones. 
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VIII. Sex Differences in Asthma and Exercise  
Strenuous exercise causes an inflammatory response tissue in skeletal muscles and 
damage is evidenced by the recruitment of leukocytes into the muscles (Paulsen et al., 
2005). The concentration of leukocytes after strenuous exercise varies by gender (St. 
Pierre Schneider et al., 1999). Compared to male mice, female mice were shown to have 
significantly reduced leukocyte concentrations in the myofibers (St. Pierre Schneider et 
al., 1999). A similar study in humans found that when males and females sustain similar 
muscle damage, women have much less inflammation (Stupka et al., 2000). In a small 
study on men, exercise was associated with increased neutrophil counts in muscle 
biopsies (Fielding et al., 1993).  
 
Joyce et al. (2014) report that hormonal contraceptives may also have an effect on 
exercise endurance. OC-using females and non-hormonally treated men reach exhaustion 
significantly quicker in cycling tests compared to naturally menstruating women. The 
experiment was designed such that the NOC females exercised during the follicular phase 
of their cycle. OC-using females exercised during the hormone withdrawal period. 
Although mean progesterone levels were deemed to be statistically similar in the 
naturally cycling and oral contraceptive using females, average estrogen levels were 
significantly reduced in women taking synthetic hormones. The authors theorized that 
endogenous estradiol is necessary for its beneficial effects on exercise endurance (Joyce 
et al., 2014).  
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Cortisol levels significantly increase in response to exercise (Kraemer et al., 1993). 
However, in a small study, no significant gender difference was found in cortisol levels 
after exercise (Szivak et al., 2013).  
 
Interestingly, exercise during puberty can reduce the risk for asthma later in life. In a ten 
year follow-up study on healthy pubescent children, high physical activity reduced the 
risk of developing asthma by 7% in adolescence (Rasmussen et al., 2000). The study also 
suggested that there was a weak correlation between reduced physical activity during 
puberty and an increased risk for asthma (Rasmussen et al., 2000). The mechanism that 
links physical activity and asthma in a positive manner needs to be investigated further.  
In asthmatic-exercise models, ovalbumin sensitized male mice that were put on an 
aerobic training protocol showed a significant reduction in inflammatory markers in 
bronchoalveolar lavage fluid and leukocyte lung migration (Vieira et al., 2014).  
 
In Kodesh et al. (2011), male Brown-Norway rats were sensitized with ovalbumin and 
challenged with one exercise bout on a treadmill. Six (27.3%) of the rats in the exercised 
and sensitized group (EXS) presented signs of respiratory distress. This evidence may 
indicate that infrequent exercise exacerbates respiratory function. As suggested by 
Rasmussen et al. (2000), exercise may need to be performed regularly to attain its asthma 
reducing benefits.  
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IX. Hypothesis and Goals of the Present Study 
In order to study asthma, allergy, and EIA pathogenesis in pubescent females, a rodent 
model has been developed to study the combined effects of exercise and an antigen. 
Evidence has shown that by sensitizing rodents with ovalbumin injections and exercise 
challenges, exercise-induced asthma can be simulated and evaluated by examining chest 
sounds using an electronic stethoscope (Kodesh et al., 2011). In the present study, OVA-
sensitized rats, un-sensitized exercise challenged rats, and OVA-sensitized exercise 
challenged rats produced abnormal lung sounds, such as wheezing (Table 13; Kodesh et 
al., 2011).  
Table 13. Classification of Auscultations. Control and exercise only group (EX) 
presented clear auscultations. Eighty percent of the sensitized only group (SS) exhibited 
increased breath sounds with elements of tone or pitch. Nearly 30% of the EXS rats 
demonstrated abnormalities. Table copied from Kodesh et al., 2011. 
 
0 
Clear breath 
sounds with 
no 
abnormalities 
1 
Increased 
breath 
sounds 
without 
elements 
of tone 
or pitch 
2 
Increased 
breath 
sounds 
with 
elements 
of tone 
or pitch 
 
Total 
Control 10 (100%) 0 0 10 
EX 15 (100%) 0 0 15 
SS 4 (20%) 0 16 (80%) 20 
EXS 16 (72.7%) 4 (18.2%) 2 (9.1%) 22 
 
Female Syrian hamsters were implanted Ortho EvraTM, a contraceptive patch that lasts for 
seven days. It was implanted during puberty with concomitant ovalbumin injections and 
exercise challenges. The control groups received sham surgeries and were injected with 
either saline or Al(OH)3 (an adjuvant used in the ovalbumin injections). It is hypothesized 
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that constant estrogen and progesterone concentrations during puberty plus OVA and 
exercise and return to estrus cycle in adulthood produce significant abnormal lung sounds 
and histopathology. 
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METHODS  
 
Table 14. Experimental Treatment Groups.  
Experimental Group Objective 
Control 
To establish a baseline of normal lung sounds and 
histology. 
EP Only 
To determine the effect of constant ovarian 
hormones during puberty and return to estrus in 
adulthood on lung sounds and histology in 
adulthood. 
EP + OVA 
To determine if there is synergy between constant 
ovarian hormones during puberty in addition to 
ovalbumin sensitization on lung sounds and 
histology in adulthood. 
EP + EX 
To determine if there is synergy between constant 
ovarian hormones during puberty in addition to 
exercise challenge sensitization on lung sounds 
and histology in adulthood. 
EP + OVA + EX 
To determine if there is synergy between constant 
ovarian hormones during puberty in addition to 
exercise challenge and ovalbumin sensitizations 
on lung sounds and histology in adulthood. 
 
I. Animals 
Pubescent, 14 day old (D14) and adult (3-4 months old) female Syrian hamsters were 
used for this study. Pubescent females were weaned from their mother at D28. Animals 
were provided food and water ad libitum and on a 14:10 light/dark schedule. This study 
was approved by the Lehigh Institutional Animal Care and Use Committee, Protocol 
#150.  
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II. Contraceptive Patch  
Ortho EvraTM is a weekly contraceptive transdermal patch. The patch has a surface area 
of 20cm2 and contains 6.0 mg of 17-deacetylnorgestimate (progestin) and 0.75 mg ethinyl 
estradiol (estrogen) (Audet et al., 2001). 
 
Figure 5. Ortho EvraTM Estrogen and Progesterone Compounds. Structure of 17-
deacetylnorgestimate and ethinyl estradiol. Copied from the Center for Drug Evaluation 
and Research Pharmacology Review (2000).  
Pre-clinical studies of the patch showed that the progestin, 17-d-NGM, is effective in 
blocking ovulation in rats at a dosage of 0.25 mg/kg of body weight or greater (Center for 
Drug Evaluation and Research Pharmacology Review, 2000). 
 
To ensure that the patch blocks ovulation in Syrian hamsters, females were implanted 
with the patch s.c. and allowed to mate with sexually experienced male conspecifics. To 
check that the females were sexually receptive before implantation, a breeder male was 
placed in the cage. If she lordosed, the male was quickly taken out of the cage to prevent 
mating. The patch should block ovulation for at least one week. To test this, females were 
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mated 1-6 days after implantation of the patch. The females were then checked at end of 
the gestational period (approximately 16 days) to ensure that there was no litter.  
Table 15. Antiovulatory Activity of Progestins. Contraceptive efficacy of norgestimate 
(NGM) and its primary metabolite,17-deacetylnorgestimate (17-d-NGM), was studied on 
rats. The antiovulatory efficacy of NGM versus 17-deacetylnorgestimate was analyzed in 
the study.  The compound, 17-d-NGM, was found to have similar efficacy via oral and 
subcutaneous routes. Ovulation was suppressed in all rats injected s.c. with 17-d-NGM at 
a dosage of 0.25 mg/kg or greater. Some boxes were intentionally left blank because that 
is how the table was produced in the article. Table was reproduced from the Center for 
Drug Evaluation and Research Pharmacology Review (2000).  
  Number of rats ovulating/10 rats treated 
 mg/kg 0 0.062 0.125 0.25 0.50 1.0 
Oral 
17-d-NGM 10 - 8 8 3 3 
NGM  - 10 9 4 2 
s.c. 
17-d-NGM 10 8 5 0 0 - 
NGM  10 5 1 0 - 
 
III. Special Considerations for Surgical Procedures 
Pubescent female hamsters at D14 need to remain with their mothers until at least D21. 
Pups cannot be immediately returned to the litter mates after completion of surgery since 
anesthetized animals could eaten by other pups in the cage.  
 
A protocol has been developed for pups that receive surgery before weaning. At the time 
of surgery, all females receiving surgery were placed in a separate cage with a heating 
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pad underneath to keep their body temperature elevated. Breeder diet food was soaked in 
water for a few seconds so it was easier for the pups to consume.  
Later in the experiment, females were weaned a week earlier than usual (D21 versus 
D28) so that wound healing was not disrupted by gnawing by litter mates.  
Sodium pentobarbital dosages were calculated as previously described but dosages were 
rounded down to prevent overdose. Upon completion of surgery, pups were placed in a 
cage separate from the mother and male pups with a heating pad underneath the cage. 
Females were not returned to their litter until the next day. This delay in returning the 
pups ensured that the hamsters had recovered from anesthesia. It also provided time for 
the surgical wound to heal and reduced the risk of the litter mates gnawing on the wound.  
IV. Ovalbumin Sensitization 
Females received 0.25 mL i.p. injection of OVA (1 mg/mL) and aluminum hydroxide 
(100 mg/ml) in a 0.9% saline solution on D14 and D21. Control subjects were injected 
with equivalent amounts of saline.  
V. Acute Ovalbumin Challenge 
Females were anesthetized with sodium pentobarbital (0.18 mL/100 g body weight; i.p.) 
and acutely challenged with 5% aerosolized OVA in 0.9% saline solution. Females were 
placed in a plastic chamber with a hole that pumped the aerosolized OVA for inhalation 
for 20 minutes. A heating pad was set to the medium heat setting and placed under the 
chamber to keep animals warm. Females were challenged 5 days per week between D28 
and D42.  
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Figure 6. Timeline of Patch Implantations, OVA-treatments, and Exercise Challenges. 
Experimental groups were injected i.p. with OVA, saline, or nothing on D14 and D21. 
Females in the exercise group started exercise challenges no earlier than D15. Females in 
the OVA or saline groups were given their first nebulizer treatments no earlier than D28. 
The last nebulizer treatment was on D43, 24 hours before sacrifice. 
VI. Exercise Challenge 
Females were challenged with exercise by allowing them to run in an exercise ball in a 
dark room for 20 minutes.  For subjects in the sensitized and exercise group, they were 
first given an exercise challenge and then underwent the acute ovalbumin challenge. 
VII. Sacrifice 
Animals were euthanized on D44, 24 hours after last antigen challenge on D43, by 
overdose of sodium pentobarbital (0.36 mL/100 g body weight; i.p.).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D0 D14  D15           D21        D28  D35          D43   D44 
 
Birth OVA or Saline i.p. 
E+P implant or Sham 
Sacrifice 
Aerosolized OVA/Saline 5 
days/week 
Exercise 5 days/week 
Sensitization Period 
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Table 16. Experimental Group I – Control. 
Group 
No 
Surgery 
OVA+ 
Al(OH)3 
Saline Al(OH)3 
EX 
1 X 
    
2 X    X 
3 X X    
4 X X 
  
X 
5 X  X   
6 X 
 
X 
 
X 
7 X 
  
X 
 
8 X   X X 
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Table 17. Experimental Group II - Sham Surgery. 
Group 
Sham 
Surgery 
OVA+ 
Al(OH)3 
Saline Al(OH)3 EX 
1 X     
2 X    X 
3 X X    
4 X X   X 
5 X  X   
6 X  X  X 
7 X   X  
8 X   X X 
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Table 18. Experimental Group III - Contraceptive Patch Implanted. 
Group 
EP 
Implant 
OVA + 
Al(OH)3 
Saline Al(OH)3 
EX 
1 X 
    
2 X 
   
X 
3 X X    
4 X X   X 
5 X  X   
6 X  X  X 
7 X 
  
X 
 
8 X 
  
X X 
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VIII. Auscultation Protocol 
To immobilize the hamsters, they were anesthetized with sodium pentobarbital (0.18 
mL/100 g body weight; i.p.). Females were shaved in the rib cage area to reduce noise. 
Using a visual electronic stethoscope (Thinklabs ds32a Digital Stethoscope), 
auscultations were recorded using Phonocardiography software.  
 
Figure 7. Asthmatic Wheeze.  Lung auscultation was recorded using a Thinklabs 
stethoscope and captured on Phonocardiography Software. Figure was copied from 
“Thinklabs Lung Sound Library,” accessed January 30, 2013, 
http://www.thinklabsmedical.com/sound-library.html.  
Currently, there are no established protocols to isolate rodent lung sounds nor 
quantifiable standards by which asthma can be categorized. As such, recordings were 
transferred to MATLAB and plotted in the time and frequency domains (using the Fast 
Fourier Transfer function). Band-pass filters were utilized to eliminate extraneous noise 
and heart sounds. Prominent frequencies were used to compare normal to asthmatic 
auscultations. Similar protocols have been used for human lung sounds (Polat and Güler, 
2004).  
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IX. Histology Protocol 
Fixation. Lungs were inflated with about 2 mL of 10% neutral buffered formalin. 
Trachea was tied with suture thread to ensure inflation of lung. Tissue was then fixed in 
the same solution until it sank to the bottom of tube.  
Paraffin Embedding. The left lobe of lung was cut in half through its parasagittal plane. 
Tissue was dehydrated using the protocol described in Table 19.  
Table 19. Paraffin Embedding Protocol. Tissue immersed in reagent and time allotted for 
each station. 
Reagent Time (hour) 
10% Neutral Buffered Formalin 1.00 
10% Neutral Buffered Formalin 2.00 
70% Ethanol 0.75 
95% Ethanol 0.75 
100% Ethanol 0.75 
100% Ethanol 0.75 
100% Ethanol 0.75 
Xylene 0.50 
Xylene 0.50 
Xylene 0.75 
Paraffin 0.75 
Paraffin 0.75 
Paraffin 1.00 
Paraffin 1.00 
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Lung Sections. Parasagittal serial sections were cut 8 µm thick. Sections were mounted 
on slides using a slide warmer.  
Deparaffinization Protocol. Tissue were deparaffinized using protocol outline in Table 
20. 
Table 20. Deparaffinization Protocol. Tissue immersed in reagent and time allotted for 
each station. 
Reagent Time 
Xylene 
10 minutes 
Xylene 10 minutes 
Xylene 10 minutes 
100% Ethanol 2 minutes 
100% Ethanol 2 minutes 
95% Ethanol 2 minutes 
Hematoxylin and Eosin Stain. Sections were stained with Gill’s II Hematoxylin and 
Eosin Y as outlined in Table 21.  Tissue samples were analyzed for inflammatory 
infiltrates using the following scale: (1) no detectable inflammation, (2) occasional 
cuffing with inflammatory cells, (3) most bronchi surrounded by a thin layer of 
inflammatory cells, and (4) most bronchi surrounded by a thick layer of inflammatory 
cells (Dimitropoulou et al., 2009).  
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Table 21. Hematoxylin and Eosin Stain Protocol. 
Hematoxylin and Eosin Stain Protocol  
(1) Deparaffinize as outlined in Table 20.  
(2) Wash sections in gently running tap water until they run “clear.” 
(3) Rinse in distilled water. 
(4) Place sections in Gills II Hematoxylin for 1.5-2 minutes. 
(5) Wash in gently running warm tap water for 1 - 2 minutes. 
(6) Place sections in eosin for 15-20 seconds. 
(7) Wash in gently running tap water to remove excess stain. 
(8) Dehydrate sections through one 95% ethanol and two changes of 100% ethanol 
for two minutes each.  
(9) Clear through 2 changes of xylene for 10 minutes each.  
(10) Coverslip slides sections with Permount. 
Congo Red Stain. To visualize and differentiate eosinophils and neutrophils, sections 
were stained with 0.5% Congo Red (0.5g Congo Red dissolved in 100 mL of 50% 
ethanol).  The protocol is outlined in Table 22. Cells were counted manually and 
averaged over 10 sections of tissue. 
Table 22. Congo Red (0.5%) Stain Protocol. 
Congo Red Stain Protocol  
(1) Deparaffinize as outlined in Table 20.  
(2) Rinse sections in distilled water. 
(3) Stain slides in Gill’s II Hematoxylin for 1-2 minutes. 
(4) Rinse in cold running tap water.  
(5) ‘Blue’ sections in luke warm tap water for 1 minute. 
(6) Briefly rinse slides in 70% ethanol. 
(7) Stain slides in 0.5% Congo Red solution for 30 minutes at room temperature. 
(8) Dip sections 5 times in 70% ethanol. 
(9) Dehydration: dip slides 3 to 4 times in 95% ethanol and two changes of 100% 
ethanol. 
(10) Tissue dehydrated in 2 changes of xylene (10 minutes each). 
(11) Coverslip slide sections with Permount. 
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RESULTS 
Presented here are results of a pilot study on the effects of synthetic ovarian steroids, 
ovalbumin sensitization, and exercise on the respiratory function in female Syrian 
hamsters. Although the histologic and lung auscultation data are inconclusive due to 
technical difficulties and human error, animal survival percentages (Figure 8) may 
indicate that non-exercised, treated females had worse survival rates than control and 
exercise-treated females.  
I. Survival 
Sixty-nine percent of the Sham + Saline (9 out of 13) group survived the experiment. The 
four females that did not survive died due to complications with anesthesia during their 
first round of surgeries at age D14. Both controls for the Al(OH)3 group survived until 
the end of the experiment.  
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Table 23. Experimental Female Survival Percentages. 
Group Total Females Survived 
Sham + Saline 13 9 
Sham + Al(OH)3 2 2 
EP + Saline Only 5 3 
EP + OVA Only 10 4 
EP + Al(OH)3 2 0 
EP + Saline + EX 7 5 
EP + OVA + EX 6 4 
Total 45 27 
 
Females that were implanted with the patch and sensitized with ovalbumin or Al(OH)3 
presented with the worst survival rates, 40% and 0%, respectively. Since there was only a 
sample size of 2 in the EP + Al(OH)3 group, it is inconclusive whether or not the 
aluminum adjuvant actually caused the zero survival rate. One female in the EP + 
Al(OH)3 group had complications with anesthesia during the first round of patch 
implants. The other EP + Al(OH)3 female needed to be euthanized 4 days after the first 
patch implant because her wound was too large to re-suture. The wound was a direct 
result of her litter mates gnawing at the wound.  
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Figure 8. Percentage of Females that Survived Treatment. 
 
Of the five females in the EP + Saline group, two females were euthanized because they 
looked sick. One female completed seven days of treatment and the other completed 29 
days. The female that completed 29 days was huddled in the corner of her cage and had 
dry, scaly skin at the time of euthanasia. 
 
Only four out of ten females in the EP + OVA group survived the experiment, suggesting 
that this treatment may have elicited the most profound effect on the immune system. Of 
the six females that did not survive the treatment, four went missing and two were 
euthanized. The four that went missing most likely died overnight and were eaten by their 
litter mates. For the two females that were euthanized, one presented with a large cyst 
under her ribcage and the other had a large wound in the area of her surgery that was not 
repairable. The wounds were direct results of her litter mates’ gnawing. All six females 
died in the first week of the treatment.  
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In the EP + Saline + EX group, five out of seven females survived the treatment. The two 
females that did not survive died from anesthesia complications after completing 19 and 
21 days of the experiment. Both females died during saline nebulizer treatments.  
 
Four out of six females in the EP + OVA + EX group completed the experiment. One 
female died due to anesthesia complications during the first round of surgeries and the 
other female completed seven days of treatment before needing to be euthanized. She was 
huddled in the corner and appeared sickly.  
 
Since the groups EP + Saline + EX and EP + OVA + EX yielded greater survival rates 
than their non-exercised treated groups, this may suggest that exercise attenuates the 
effects of ovarian sex steroids and ovalbumin sensitization during puberty.  
II. Changes in Mass 
For the females that completed the experiment, the change in mass was calculated in the 
following manner: subtract the mass of the females at euthanasia from the mass at first 
surgery. The mean change in mass and standard deviations were calculated for each 
group. The Sham + Saline group presented with the largest increase in weight gain (79.2g 
± 6.3 g). Interestingly, the EP + OVA + EX, EP + Saline + EX, and Sham + Al(OH)3 
groups presented with similar mass gains: 72.3g ± 4.1g, 70.1g ± 1.7g, and 71.5g ± 1.4g, 
respectively. The non-exercised treated groups produced the smallest change in weights:  
EP + Saline Only (64.1g ± 2.4g) and EP + OVA (66.8g ± 6.8g).  
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Table 24. Average Female Mass Gains. Females were weighed on the first and last days 
of the experiment. The difference in mass was calculated. For each group, the masses 
were averaged and the standard deviation was calculated. 
Group n 
Change in Mass: 
Average ± Standard Deviation  (g) 
Sham + Saline 9 79.2 ± 6.3 
Sham + Al(OH)3 2 71.5 ± 1.4 
EP + Saline Only 3 64.1 ± 2.4 
EP + OVA Only 4 66.8 ± 6.8 
EP + Saline + EX 5 70.1 ± 1.7 
EP + OVA + EX 4 72.3 ± 4.1 
 
III. Contraceptive Efficacy of the Patch 
Three adult females were implanted with the patch. Female #1 (164g) was implanted with 
the patch on the same day that she was tested for lordosis. The next day she lordosed 
again and was allowed to mate. Female #1 did not produce a litter. 
 
Female #2 (154g) tested positive for sexual receptivity on a previous date. She was 
implanted with a 1cm x 0.5cm patch and mated 3 days after implantation. Female #2 did 
not produce a litter. 
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Female #3 (168g) tested positive for sexual receptivity on a previous date. She was 
implanted with a 1cm2 patch and mated 6 days after implantation. Female #3 produced a 
litter 16 days after mating.  
IV. Lung Auscultation 
Technical difficulties were encountered with lung auscultation analysis. It was not 
discovered until the end of the experiment that all recordings were noise. The electronic 
stethoscope was mistakenly connected to the audio jack instead of the microphone port.  
V. Histology 
Technical issues were also encountered in histologic processing, mainly the process of 
correctly inflating the tissue with fixative and embedding it with paraffin. Tissue was 
either under- or overinflated. Problems with the paraffin embedding process made slicing 
the tissue difficult.  
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DISCUSSION 
 
I. Overview 
To date, this is the first study that tested the effects of the contraceptive patch, ovalbumin 
sensitization, and chronic exercise challenges during puberty and adulthood. Based on the 
limited data that were produced in this study, survival percentages and changes in mass 
gain suggest several key points: (1) the combined contraceptive patch during puberty has 
an impact on the female immune system, (2) there is an increased inflammatory effect 
between the ovarian sex steroids and ovalbumin sensitization, and (3) exercise attenuates 
the effects of the contraceptive patch and ovalbumin sensitization during puberty. Lastly, 
the contraceptive patch does prevent pregnancy in Syrian hamsters if mated within 3 days 
of implantation. It is unknown if the patch blocks ovulation on days 4 and 5 after 
implantation as females were not mated on these days. Although the female that was 
mated six days after implantation produced a litter, pubescent females are much smaller 
when they are implanted with the patch. It is reasonable to suggest that the contraceptive 
patch lasts at least a week in the smaller, pubescent females.  
II. Technical Concerns 
As this is a pilot study, there are numerous challenges that arose throughout the 
experiment. First, not all females received the same protocol as outlined in the Methods 
section. There were several incidents of inclement weather during the study that 
prevented me from going to the lab. As a result, many females did not receive the five 
exercise and nebulizer challenges. Next time, time-sensitive experiments will not be 
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conducted during the height of winter. Instead, that time frame would be a great 
opportunity to work on less time-sensitive lab work such as data analysis.  
 
There were also issues identifying the females from among their litter mates due to ear 
marks that became ambiguous. The double ear marks on the same ear often became one 
large ear mark. For future studies, this can be avoided by using fewer females from the 
same litter.  
 
Second, many females died due to complications with anesthesia. At two weeks of age, 
hamsters are very small, often less than 20g. As such, it is very easy for hamster pups to 
overdose on anesthetic. For future experiments on young hamsters, the sodium 
pentobarbital should be diluted with sterile water and injected with smaller syringes to 
ensure accurate dosage delivery.  
 
Third, there were challenges with the surgical procedure designed to implant the 
contraceptive patch. The sutures at the site of implantation would often come undone due 
to gnawing by the litter mates. Since the pups cannot be weaned from their mother before 
21 days old, it was important to make sure that the sutures were tight. After the first 
surgical implant at 14 days old, females were group housed overnight in a mouse cage 
with a heating pad underneath the cage with a mouse water bottle and food. For extra 
comfort, hamsters were provided water soaked pellets for easier eating. The extra time 
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away from their non-anesthetized litter mates and mother allowed for more healing time 
and complete recovery from anesthesia.  
 
Halfway through the experiment, females were weaned at D21 days instead of D23 days 
and independently housed in mouse cages with torn paper napkins to create a nest. 
Initially, the females were weaned and group housed in the larger hamster cages. They 
appeared happier in the smaller cage. Daily checks were performed to assess their health 
and to see if the females outgrew their cage. If they became too large for the mouse cage, 
they were housed in the larger hamster cage.   
 
The data acquistion (i.e., lung auscultations and tissue for histology) presented 
challenges. While analyzing the lung sounds, it was discovered that the recordings were 
just noise. The electronic stethoscope was supposed to be plugged into the microphone 
port, not the audio port. This should have been verified at the beginning of the study.  
 
For the histological analysis, difficulties were attributed to inexperience with harvesting 
and inflating the lung and processing and slicing the tissue. Harvesting lung tissue takes a 
bit of practice. It requires locating the trachea and delicately cutting connective tissue that 
holds the lungs inside the rib cage. Some of the samples were not inflated because too 
much of the trachea was cut or the lungs were nicked with scissors. Tissue samples that 
were embedded with paraffin also presented challenges. There was difficulty finding the 
appropriate protocol to balance dehydrating the tissue and allowing the paraffin to 
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infiltrate the tissue. Some samples were over dehydrated and others were not fully 
embedded with the wax. For future experiments, it will be necessary to harvest practice 
lung tissue and vary the times that the samples are dehydrated in the increasing grades of 
ethanol to find the optimal protocol.  
 
Overall, this was a great learning experience. Through trial and error, various techniques 
and protocols were developed. A test run of the experiment on a smaller scale would have 
been useful in order to troubleshoot any challenges. For the surgeries on the pups, the 
anesthetic will need to be diluted and smaller, more precise syringes utilized for accurate 
dosage delivery. 
 
Organization is also key for future experiments. The difficulty of taking on a completely 
original project was underestimated and the time it would take to become proficient in the 
protocols was not taken into account. Better organization could have prevented several 
mistakes in the actual experiment and stronger data may have been produced.  
III. Conclusions and Future Experiments 
Even after all of the challenges that this experiment has presented it did yield some 
successes. This experiment is the first to outline an idea and protocol for understanding 
the effects of contraceptive hormones, ovalbumin sensitization, and exercise during 
puberty on the predisposition for asthma in adulthood. Ovalbumin sensitization in rodents 
is a well-documented animal model to study asthma (Dimitropoulou et al., 2009; Kodesh 
et al., 2011; Riffo-Vasquez et al., 2007). Some studies also suggest that chronic exercise 
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can reduce asthma symptoms later in life (Rasmussen et al., 2000; Vieira et al., 2014). It 
is not clear why some animal studies show attenuation or increased respiratory symptoms 
under high (Dimitropoulou et al., 2009) and low (Riffo-vasquez et al., 2007) levels of 
estrogen, respectively.  As such, it is necessary to repeat this experiment to see if 
contraceptives during puberty are the reason why some females respond better to high 
levels of estrogen and others to low levels.  
 
Endogenous ovarian steroids are reduced during hormonal contraceptive treatment due to 
negative feedback mechanisms. How the immune system responds to the return of natural 
menstrual cycles remains to be elucidated. A future experiment may be done by 
implanting the patch again in adulthood to see if it improves respiratory function and 
reduces inflammation. If this has positive results, then it can be suggested that hormonal 
contraceptives during puberty permanently alter the immune system’s threshold for 
certain levels of sex steroids.  
 
The stress response was not evaluated in this study but will be completed as a future 
study. Adults and prepubescent/adolescent react to stress differently with respect to 
cortisol levels (Girard-Joyal et al., 2015; Romeo et al., 2004; Romeo et al., 2006). It is 
also known that combined hormonal contraceptives significantly increase cortisol levels 
(Timmons et al., 2005). It is unknown if cortisol levels are increased in pubescent 
females on hormonal contraceptives to the same extent that adults on contraceptives have 
substantially greater cortisol levels. If cortisol levels are increased in pubescent females 
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treated with contraceptives and they are taken off the drug in adulthood, do their immune 
systems acclimate to the higher threshold of cortisol? This question is critical to answer 
as severe asthmatics have reduced sensitivities to glucocorticoid treatment (Chang et al., 
2015). As such, if the immune systems of pubescent females are adjusting to larger 
thresholds in cortisol, it is plausible that when the female is taken off contraceptives, her 
cortisol levels drop and her immune system requires more cortisol to suppress the 
immune system and reduce pulmonary inflammation.  
 
This is the first study to attempt to study the role of hormones during puberty as a factor 
in the later development of respiratory dysfunction. Researchers often look for the one 
trigger that causes asthma. However, based on EIA case studies, it is possible to require 2 
simultaneous allergens to elicit a response. For other asthmatics, the synergistic allergen 
may not even be exercise. For example, someone could only have an allergic reaction 
when exposed to pollen and eating wheat pasta. That same person might not have the 
same reaction if he or she is independently exposed to pollen or wheat. This type of 
synergistic reaction needs to be researched further. Since females are more likely than 
males to develop asthma after puberty, it is plausible that there is a hormonal component. 
Future research will require being mindful of the hormonal status of their subjects.  
 
 
Although the study did not produce concrete data, the survival rates could suggest that 
the chronically exercised groups had reduced a inflammatory response. This is in 
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alignment with the study that showed active lifestyles during puberty reduced the risk of 
asthma later in life (Rasmussen et al., 2000). In the study by Kodesh et al. (2011), 
ovalbumin sensitization and a single exercise challenge produced worsening of the lung 
sounds compared to non-exercised, sensitized group. This can be argued that chronic 
exercise is necessary for improved pulmonary function. Overall, this study is a start to 
paving the way for future endeavors in understanding the pathogenesis of EIA.  
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